Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-8.05%
↓ 145% below average
Average (39q)
18.01%
Historical baseline
Range
High:333.15%
Low:-25.24%
Volatility
1990.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -8.05% |
| Q2 2025 | 29.71% |
| Q1 2025 | -25.24% |
| Q4 2024 | 24.91% |
| Q3 2024 | -5.78% |
| Q2 2024 | 37.73% |
| Q1 2024 | -20.84% |
| Q4 2023 | 32.48% |
| Q3 2023 | -11.51% |
| Q2 2023 | 11.51% |
| Q1 2023 | -9.99% |
| Q4 2022 | 19.44% |
| Q3 2022 | 1.23% |
| Q2 2022 | 9.80% |
| Q1 2022 | -7.57% |
| Q4 2021 | 3.11% |
| Q3 2021 | -7.59% |
| Q2 2021 | -11.01% |
| Q1 2021 | 9.47% |
| Q4 2020 | 8.77% |
| Q3 2020 | 32.08% |
| Q2 2020 | 50.47% |
| Q1 2020 | 30.59% |
| Q4 2019 | 31.88% |
| Q3 2019 | -1.14% |
| Q2 2019 | 31.96% |
| Q1 2019 | 12.48% |
| Q4 2018 | 37.11% |
| Q3 2018 | -9.19% |
| Q2 2018 | 21.06% |
| Q1 2018 | 333.15% |
| Q4 2017 | 104.01% |
| Q3 2017 | -3.04% |
| Q2 2017 | -13.98% |
| Q1 2017 | -1.04% |
| Q4 2016 | -4.41% |
| Q3 2016 | -12.20% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |